PsiOxus Therapeutics Updates Agreement with Bristol Myers Squibb to Advance their Clinical …,

The first stage of this collaboration combined Bristol Myers Squibb’s Opdivo with PsiOxus’ enadenotucirev in the Phase 1 SPICE study to determine the …, The first stage of this collaboration combined Bristol Myers Squibb’s Opdivo with PsiOxus’ enadenotucirev in the Phase 1 SPICE study to determine the …, Read More

Scroll to Top